Skip to main content

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Evaluación ultra-rápida en la sala de angiografía vs. tomografía convencional en la indicación del tratamiento endovascular del ictus agudo.

IP: Marc Ribó Jacobi
Collaborators: Manuel Requena Ruiz
Funding agency: Fundació Institut de Recerca HUVH
Funding: 35000
Reference: HUVH/BPFSE/2019/REQUENA
Duration: 01/06/2019 - 31/05/2020

FARMALARM: Integral communication platform and intelligent clinical follow-up

IP: Marc Ribó Jacobi
Collaborators: -
Funding agency: Fundació Barcelona Mobile World Capital Foundation
Funding: 2000
Reference: FBMWCF/COLLIDER/2019/RIBO
Duration: 21/06/2019 - 19/03/2020

App for Smartphones to induce healty lifestyle modification and therapeutic compliance monitoring in stroke secondary prevention in multiple centers across Catalunya

IP: Marc Ribó Jacobi
Collaborators: Carlos Molina Cateriano, Estefania Montiel
Funding agency: Fundació La Marató de TV3
Funding: 149990
Reference: 20172810
Duration: 01/01/2018 - 31/12/2021

Computarized Tomography Perfusion to characterize lack of clinical improvement AFTer RECanalization in acute ischemic stroke (CTP_AFT_REC)

IP: Marta Aurora Rubiera Del Fueyo
Collaborators: Marc Ribó Jacobi, Alejandro Tomasello Weitz
Funding agency: Fundació La Marató de TV3
Funding: 199955
Reference: 20173210
Duration: 01/01/2018 - 31/12/2020

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Mercè Roca Lòpez

Mercè Roca Lòpez

Administration and Management
Read more
Remedios Rios Barrera

Remedios Rios Barrera

Senior researcher
Cardiovascular Diseases
Read more
Yassin Belahnech Pujol

Yassin Belahnech Pujol

Main researcher
Cardiovascular Diseases
Read more
Hakima Ouaarab Essadek

Hakima Ouaarab Essadek

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.